Shire Settles Intuniv Infringement Case Against Impax
Impax Laboratories Inc. has agreed to license Shire PLC's patents for the attention deficit hyperactivity disorder drug Intuniv, resolving Shire's infringement litigation over Impax's bid to launch a generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article